FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.24 | FHIR Version n/a User: [n/a]

718844003: cabozantinib (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\inhibiteur de la transférase\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Cabozantinib (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\Cabozantinib (substance)

\Drug or medicament (substance)\Antineoplastic agent (substance)\Cabozantinib (substance)
\Drug or medicament (substance)\Quinoline\Cabozantinib (substance)

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\...

\Amine and/or amine derivative\Quinoline\Cabozantinib (substance)

\Pyridine and/or pyridine derivative\Pyridine\Cabozantinib (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Pyridine\Cabozantinib (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoline\Cabozantinib (substance)
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Cabozantinib (substance)
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Cabozantinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2017. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cabozantinib (substance)	Has disposition (attribute)	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
Cabozantinib (substance)	est un(e) (attribut)	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some
Cabozantinib (substance)	est un(e) (attribut)	Pyridine	true	Inferred relationship	Some
Cabozantinib (substance)	est un(e) (attribut)	Quinoline	true	Inferred relationship	Some
Cabozantinib (substance)	est un(e) (attribut)	Antineoplastic agent (substance)	true	Inferred relationship	Some
Cabozantinib (substance)	est un(e) (attribut)	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Cabozantinib (substance)	Has disposition (attribute)	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Cabozantinib (substance)	est un(e) (attribut)	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Cabozantinib (substance)	est un(e) (attribut)	Enzyme inhibitor	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only cabozantinib (medicinal product)	a pour principe actif (attribut)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Cabozantinib only product in oral dose form	a pour principe actif (attribut)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Cabozantinib s-malate	Is modification of (attribute)	True	Cabozantinib (substance)	Inferred relationship	Some
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule	Has basis of strength substance (attribute)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet	Has basis of strength substance (attribute)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Product containing cabozantinib (medicinal product)	a pour principe actif (attribut)	True	Cabozantinib (substance)	Inferred relationship	Some	1
Product containing cabozantinib in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Cabozantinib (substance)	Inferred relationship	Some	1

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3314044011	Cabozantinib (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3314045012	Cabozantinib	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
753171000241110	cabozantinib (substance)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
796631000172112	cabozantinib	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)